This article was originally published here

J Sex Med. 2020 Oct 9:S1743-6095(20)30936-X. doi: 10.1016/j.jsxm.2020.09.013. Online ahead of print.

ABSTRACT

BACKGROUND: Men who contract coronavirus disease 2019 (COVID-19) appear to have worse clinical outcomes compared with women which raises the possibility of androgen-dependent effects.

AIM: We sought to determine if testosterone replacement therapy (TRT) is associated with worse clinical outcomes.

METHODS: Through a retrospective chart review, we identified 32 men diagnosed with COVID-19 and on TRT. They were propensity score matched to 63 men diagnosed with COVID-19 and not on TRT. Data regarding comorbidities and endpoints such as hospital admission, intensive care unit admission, ventilator utilization, thromboembolic events, and death were extracted. Chi-square and Kruskal-Wallis tests examined differences in categorical and continuous variables, respectively. Logistic regression analysis tested the relationship between TRT status and the study endpoints.

RESULTS: There were no statistically significant differences between the 2 groups, and TRT was not a predictor of any of the endpoints on multivariate analysis.

CONCLUSION: These results suggest that TRT is not associated with a worse clinical outcome in men diagnosed with COVID-19. Rambhatla A, Bronkema CJ, Corsi N, et al. COVID-19 Infection in Men on Testosterone Replacement Therapy. J Sex Med 2020;XX:XXX-XXX.

PMID:33191186 | DOI:10.1016/j.jsxm.2020.09.013

See the original post here:
COVID-19 Infection in Men on Testosterone Replacement Therapy - DocWire News